SCHEMBL21573335

SCHEMBL21573335

CC(Nc1nc(NCC(F)(F)F)nc(-c2cccc(C(F)(F)F)n2)n1)C(F)(F)F

nearest known ligand 0.65

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ IDH1 O75874 18/20 0.65
▸ IDH2 P48735 7/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16393283 0.90 IDH1 (0.79) IDH1IDH2
SCHEMBL16393075 0.90 IDH1 (0.79) IDH1IDH2
SCHEMBL21573412 0.89 IDH1 (0.67) IDH1IDH2
SCHEMBL18557108 0.87 IDH1 (0.87) IDH1IDH2
SCHEMBL17971618 0.87 IDH1 (0.87) IDH1IDH2
SCHEMBL21573251 0.86 IDH1 (0.81) IDH1IDH2
SCHEMBL21573248 0.85 IDH1 (0.58) IDH1IDH2
SCHEMBL29975808 0.81 IDH1 (0.89) IDH1IDH2
SCHEMBL21573307 0.81 IDH1 (0.89) IDH1IDH2
SCHEMBL16392938 0.81 IDH1 (0.89) IDH1IDH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3686190-A1 SYNTHESIS OF THERAPEUTICALLY ACTIVE COMPOUNDS Agios Pharmaceuticals, Inc. (US) 2020-07-29 — — EP disclosed
EP-3019483-B1 THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE AGIOS PHARMACEUTICALS INC (US) 2019-11-20 — — EP disclosed
Send feedback